@inproceedings{inproceedings, title  = {{The cost-effectiveness of adalimumab (HUMIRA (TM), Abbott) in patients with rheumatoid arthritis: A Swedish analysis.}},

 url = {{}},

 year = {{2003}},

 month = {{9}},

 author = {{Bansback NJ and Brennan A and Ghatnekar O and Sengupta N and Chang KY and Hansen M}},

 volume = {{48}},

 journal = {{ARTHRITIS AND RHEUMATISM}},

 issue = {{9}},

 pages = {{S611-S611}},

 note = {{Accessed on 2024/09/20}}}